Outcome | Baseline | Month 6 | |||||
---|---|---|---|---|---|---|---|
Control (n = 45) | Intervention (n = 58) | p* | Control (n = 41) | Intervention (n = 57) | p* | Beta (SE); p | |
CC knowledge | 4.76 (2.60) | 5.57 (2.83) | 0.14 | 6.13 (2.93) | 11.48 (3.60) | < 0.001 | 4.80 (0.67); <0.001 |
CC enacted stigma | 1.76 (0.57) | 1.81 (0.58) | 0.63 | 1.60 (0.36) | 1.65 (0.41) | 0.55 | 0.07 (0.08); 0.37 |
CC risk management self-efficacy | 6.96 (1.57) | 7.40 (1.46) | 0.14 | 6.59 (2.11) | 9.47 (4.20) | < 0.001 | 2.75 (0.73); <0.001 |
CC screening self-efficacy | 1.92 (0.12) | 1.91 (0.14) | 0.36 | 1.98 (0.06) | 2.00 (0) | 0.03 | 0.05 (0.03); 0.10 |
CC prevention advocacy | 1.76 (0.48) | 1.83 (0.68) | 0.55 | 1.69 (0.69) | 3.41 (1.36) | < 0.001 | 1.75 (0.23); <0.001 |